Skip to main content
. 2021 Jun 28;11:13376. doi: 10.1038/s41598-021-92881-x

Table 2.

Description of interactions between the MMP-9 domains.

PRO/CAT HPX Type Terminal inhibitory complex Circular heterohexamer
Glu53 Ala647 VdW +
Tyr54 Arg652 HB, VdW +
Arg56 Asp634 Elect, HB +
Arg645 VdW +
Ser646 VdW +
Val57 Leu632 VdW +
Arg634 VdW +
Ser646 VdW +
Ser648 VdW +
Glu59 Arg634 Elect, HB +
Leu73 Glu649/Met653 VdW, VdW +
Asp652 VdW +
Lys76 Glu649 Elect, HB +
Asp651 Elect, HB +
Leu104 Ala647 VdW +
Arg106 Asp609 Elect, HB  + 
Phe110 Ala608 VdW +
Gly112 Arg600 VdW +
Ala608 VdW +
Asp113 Arg585/Arg600 Elect, HB/Elect, HB +
Leu114 Ala608 VdW +
Asp609 VdW +
Phe222 Gln586 HB +
Pro598 VdW +
Asn224 Pro564 VdW  + 
Arg249 Val595 VdW +
Gly597 HB +
Asp251 Val595 VdW +
Asp263 Arg546 Elect, HB +
Thr264 Arg546 VdW +
Asp266 Arg565 Elect, HB +
Phe268 Pro561/Pro564 VdW/VdW  + 
Ala562 VdW +
Leu563 VdW +
Phe270 Pro598 VdW +
Glu427 Arg677 Elect, HB +
Tyr696 HB +

Hydrogen bonds (HB), Van der Waals (VdW), and Coulomb electrostatic interactions (Elect) are marked as follows: ‘+’ indicates stable interactions and ‘−’ the absent ones.